Revolution Medicines Stock Investor Sentiment

RVMD Stock  USD 36.79  0.12  0.33%   
About 76 percent of Revolution Medicines' shareholders are selling. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that quite a large number of traders are terrified. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.

Comfort Level 24

 Terrified

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Revolution Medicines' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Revolution Medicines.

Revolution Historical Sentiment

Although Revolution Medicines' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Revolution, such as negative comments on social media and news outlets, may cause fear in the market and push Revolution Medicines' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Revolution.

Revolution Medicines Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Revolution Medicines Historical Investor Sentiment

Investor biases related to Revolution Medicines' public news can be used to forecast risks associated with an investment in Revolution. The trend in average sentiment can be used to explain how an investor holding Revolution can time the market purely based on public headlines and social activities around Revolution Medicines. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Revolution Medicines' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Revolution Medicines and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Revolution Medicines news discussions. The higher the estimate score, the more favorable the investor's outlook on Revolution Medicines.

Revolution Medicines Maximum Pain Price Across September 19th 2025 Option Contracts

Revolution Medicines' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Revolution Medicines close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Revolution Medicines' options.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Revolution Medicines' Stock prices. Below is the latest headlines and news related to Revolution Medicines Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Revolution Medicines that are available to investors today. This information is accessible both publicly - through Revolution Medicines' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Revolution-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Revolution Medicines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revolution Medicines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revolution Medicines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revolution Medicines alpha.

Revolution Largest EPS Surprises

Earnings surprises can significantly impact Revolution Medicines' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-02-28
2021-12-31-0.64-0.71-0.0710 
2023-05-08
2023-03-31-0.81-0.720.0911 
2021-11-10
2021-09-30-0.63-0.72-0.0914 
2023-08-08
2023-06-30-0.82-0.92-0.112 
2020-08-10
2020-06-30-0.36-0.46-0.127 
2021-03-02
2020-12-31-0.38-0.52-0.1436 
View All Earnings Estimates
2 days ago at gurufocus.com         
Revolution Medicines and Summit Therapeutics Announce Clinical Collaboration RVMD stock news
Gurufocus Stories at Macroaxis
2 days ago at gurufocus.com         
Revolution Medicines Enters Partnership with Summit Therapeutics
Gurufocus Stories at Macroaxis
3 days ago at thelincolnianonline.com         
Goodman Advisory Group LLC Takes 127,000 Position in Revolution Medicines, Inc.
news
few days ago at thelincolnianonline.com         
Revolution Medicines Buy Rating Reiterated at Needham Company LLC
news
six days ago at gurufocus.com         
Revolution Medicines Receives Buy Rating Reiteration from Guggenheim RVMD ...
Gurufocus Stories at Macroaxis
six days ago at thelincolnianonline.com         
Revolution Medicines Given Buy Rating at Guggenheim
news
over a week ago at gurufocus.com         
Revolution Medicines Secures 2B Funding with Royalty Pharma Partnership
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Revolution Medicines Maintains Buy Rating as Analyst Reiterates Price Target RVMD ...
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Revolution Medicines Shares Gap Down Heres What Happened
news
over a week ago at finance.yahoo.com         
Revolution Medicines Enters Into 2 Billion Flexible Funding Agreement with Royalty Pharma to Support...
Yahoo News
over a week ago at gurufocus.com         
Revolution Medicines Enters Into 2 Billion Flexible Funding Agreement with Royalty Pharma to ...
Gurufocus Stories at Macroaxis
over a week ago at globenewswire.com         
Revolution Medicines Enters Into 2 Billion Flexible Funding Agreement with Royalty Pharma to Support...
Macroaxis News: globenewswire.com
over a week ago at gurufocus.com         
Revolution Medicines Earns FDA Breakthrough Status for Cancer Drug RVMD Stock News
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Revolution Medicines Gains After FDA Grants Breakthrough Status
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Revolution Medicines Inc Receives FDA Breakthrough Therapy Designation for Daraxonrasib ...
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Revolution Medicines that are available to investors today. This information is accessible both publicly - through Revolution Medicines' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Revolution-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Revolution Medicines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revolution Medicines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revolution Medicines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revolution Medicines alpha.

Revolution Medicines Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 4665 shares by Kelsey Stephen Michael of Revolution Medicines at 44.1853 subject to Rule 16b-3
04/25/2025
2
Acquisition by Mark Goldsmith of 97400 shares of Revolution Medicines subject to Rule 16b-3
05/02/2025
3
The Manufacturers Life Insurance Company Purchases 24,698 Shares of Revolution Medicines, Inc.
05/05/2025
4
Disposition of 2173 shares by Wei Lin of Revolution Medicines at .83 subject to Rule 16b-3
06/12/2025
5
Avanza Fonder AB Sells 1,073 Shares of Revolution Medicines, Inc.
06/13/2025
6
This Revolution Medicines Insider Increased Their Holding In The Last Year
06/20/2025
7
Revolution Medicines Earns FDA Breakthrough Status for Cancer Drug RVMD Stock News
06/23/2025
8
Revolution Medicines Maintains Buy Rating as Analyst Reiterates Price Target RVMD ...
06/24/2025
9
Revolution Medicines Buy Rating Reiterated at Needham Company LLC
06/27/2025
10
Revolution Medicines Enters Partnership with Summit Therapeutics
06/30/2025

Complementary Tools for Revolution Stock analysis

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios